Psychedelics Business

Novamind Adding 4 Psychedelic Mental Health Clinics, Doubling Size of Network
Novamind, a mental health company that specializes in psychedelic medicine, has announced plans to open 4 new Cedar Psychiatry clinics in Utah, which will double its network to 8 locations in the state overall.
MindMed Begins Trading on Nasdaq
Psychedelic medicine biotech firm MindMed began trading shares on the Nasdaq Capital Market on Tuesday.
Perspectives
Adoption of Psychedelic-Assisted Therapy Shows Path for Other Practices
Aside from its clinical value, psychedelic-assisted therapy offers important lesson on the adoption of healthcare practices, and its worth understanding how psychedelics have gained support in medical circles.
Mass General Opens Center to Study Psychedelics in Treatment of Mental Illness
Massachusetts General Hospital recently announced the opening of a new program to study the use of psychedelics to treat mental illnesses, including depression, anxiety and PTSD.
Aion Therapeutic Opens International Center in Jamaica
Aion Therapeutic has announced the opening of the Aion International Center for Psychedelic Psychiatry, a Jamaica-based facility that will specialize in the use of psilocybin in treating addiction, depression, major depressive disorder, and other mental health conditions.
Field Trip Health Opens Houston Center, Plans 5 More Facilities
Psychedelic therapy and drug development firm has opened a new center in the Houston area and announced plans for five more facilities across North America.

Videos

Learning Network Announces Sana Symposium, a Psychedelics-Focused Virtual Education Event
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
Back to Top